Federal award (BPA CALL, fiscal year 2021)
Recipient: STEMCELL TECHNOLOGIES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-05-27 to 2022-06-27
Current total value of award: $10944.6
Description: 22-011039 MCHB REQUIRES G-CSF MOBILIZED HUMAN PERIPHERAL BLOOD CD34+ CELLS IN ORDER TO FOR OUR STUDY ABOUT THE DRUG CANDIDATES TESTING OF OLFM4 INHIBITION.